Randomized Study of Midodrine, an Alpha Adrenergic Agonist, in Patients With Neurally Mediated Syncope
NCT00004479 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
OBJECTIVES:
Determine the efficacy of midodrine, a selective alpha 1 adrenergic agonist, in preventing neurally mediated syncope.
Conditions
- Syncope
Interventions
- DRUG
-
midodrine
Sponsors & Collaborators
-
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Horacio Kaufmann · Icahn School of Medicine at Mount Sinai
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-03-31
Countries
- United States
Study Locations
More Related Trials
-
Non-Pharmacologic Therapy for Neurocardiogenic Syncope
NCT00096902 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial for the Prevention of Vasovagal Syncope
NCT00118482 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
NCT02897063 ·Status: RECRUITING ·Phase: PHASE1
-
Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic Hypotension
NCT00555880 ·Status: COMPLETED ·Phase: PHASE4
-
The Effectiveness of Metoprolol in the Prevention of Syncope Recurrence in Children and Adolescents
NCT00475462 ·Status: COMPLETED ·Phase: NA
-
Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects
NCT02123056 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Dose Response Trial Using 5 and 10 Mg of Midodrine Hydrochloride
NCT00426842 ·Status: COMPLETED ·Phase: PHASE2
-
Using Clonidine to Improve Leg Weakness in People With Heart Failure
NCT00858845 ·Status: COMPLETED ·Phase: PHASE4
-
Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist
NCT03070730 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study of Atomoxetine in the Prevention of Vasovagal Syncope
NCT05159687 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Nicorandil on Cardiac Sympathetic Nerve for the Patients of Acute ST Segment Elevation Myocardial Infarction
NCT04826497 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients
NCT04620382 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Hemodynamic Response to Prolonged Dobutamine Infusion
NCT01042873 ·Status: UNKNOWN ·Phase: PHASE4
-
Propranolol to Treat Fainting Due to Sympathoadrenal Imbalance
NCT00060866 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in Subjects With Neurogenic Orthostatic Hypotension
NCT07089043 ·Status: RECRUITING ·Phase: PHASE2
-
The Effects Of Bronchodilator Therapy On Respiratory And Autonomic Function In Patients With Familial Dysautonomia
NCT01987219 ·Status: COMPLETED ·Phase: PHASE3
-
The Pathophysiology of Orthostatic Hypotension
NCT00748059 ·Status: COMPLETED ·Phase: PHASE1
-
Hypnosis in Autonomic Function
NCT00061009 ·Status: COMPLETED
-
Theophylline for Low Adenosine Syncope
NCT03803215 ·Status: COMPLETED
-
Relation Between Vasovagal Tendency and Smoking Among University Students
NCT02949804 ·Status: COMPLETED
-
Pilot Study On The Role Of Nitric Oxide In Alpha 1-Adrenergic Vasoreactivity
NCT00240058 ·Status: COMPLETED ·Phase: NA
-
Empiric Quinidine for Asymptomatic Brugada Syndrome
NCT00789165 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Midodrine for the Early Liberation of Vasopressor Support in the ICU
NCT04489589 ·Status: COMPLETED ·Phase: PHASE4
-
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
NCT02429557 ·Status: COMPLETED ·Phase: PHASE1
-
Intravenous Norepinephrine for Orthostatic Hypotension
NCT01285908 ·Status: COMPLETED ·Phase: PHASE1/PHASE2